• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.

    BMJ Finds More Irregularities in Trial Data for Az`s Brilinta

    FIERCE PHARMA

    Datroway approved in US as first TROP2 Therapy for Lung Cancer

    BUSINESSWIRE

    Eccogene Starts Phase 1b Trial of AZD5004/ECC5004 in China

    GLOBENEWSWIRE

    Sheffield & Astra Zeneca Develop for Inverse Protein Folding

    EXPRESSPHARMA

    AZ touts Ultomiris Results in Post-Transplant Complication Trial

    FIERCE PHARMA

    AstraZeneca Signs AI Research Deal with CSPC for Chronic Disease

    REUTERS

    Syntimmune Shareholders Win Again Over AZ, time for $181M

    FIERCE BIOTECH

    Quell Therapeutics Hits Milestone in CAR-Treg for IBD

    GLOBENEWSWIRE

    IonQ accelerates drug development with AstraZeneca, AWS, NVIDIA

    BUSINESSWIRE

    Enhertu Phase 3 Trial Begins for HER2+ Endometrial Cancer

    BUSINESSWIRE

    EU Approves Calquence-Based Regimens for CLL Patients

    PRESS RELEASE

    SERENA-6 Trial Shows Guardant360 CDx Test Value in Breast Cancer

    BUSINESSWIRE

    Enhertu+Pertuzumab Cuts Risk 44% in HER2+ Breast Ca Ph3

    BUSINESSWIRE

    Camizestrant Reduced Risk of Disease Progression or Death by 56%

    BUSINESSWIRE

    Camizestrant Cuts Risk 56% In ESR1+ HR+ Breast Cancer Trial

    BUSINESSWIRE

    Imfinzi Regimen Cuts Progression Risk 29% In Gastric Cancer

    BUSINESSWIRE

    Datroway Shows Promising Tumor Responses in Lung Cancer

    BUSINESSWIRE

    Enhertu Reduces Death Risk by 30% vs Ramucirumab Plus Paclitaxel

    BUSINESSWIRE

    AstraZeneca Settles for $51 Million in Seroquel Antitrust Case

    REUTERS

    Pfizer-Arvinas Breast Cancer Drug tops AstraZeneca

    REUTERS

    AstraZeneca India approved for new use of Osimertinib

    EXPRESSPHARMA

    Enforcement Report - Week of May 28, 2025

    FDA

    Zentiva Inks 220M Deal for Former Astra Zeneca GI Drug in Europe

    FIERCE PHARMA

    AZ, Merck Duke It out To Lead Oncologists’ Pharma Perceptions

    FIERCE PHARMA

    Aptar Digital Health, AstraZeneca Partner on AI Screening

    BUSINESSWIRE

    AstraZeneca`s record year at ASCO Advances Cancer Care

    BUSINESSWIRE

    IDEA ranks Lilly, AZ as biopharma`s top Innovators, Inventors

    FIERCE PHARMA

    TGA Seeks Feedback on International Clinical Trial Guidelines

    RAPS

    Ph 3 trial shows Airsupra as standard rescue treatment in Asthma

    BUSINESSWIRE

    Global Coalition Starts AZD1390 in GBM AGILE Trial

    PR NEWSWIRE

    AstraZeneca to present respiratory research at ATS 2025

    BUSINESSWIRE

    AZ`s Imfinzi checks off a win in high-risk bladder cancer study

    FIERCE PHARMA

    Imfinzi® Regimen Shows Significant Improvement in Bladder Cancer

    BUSINESSWIRE

    AstraZeneca`s Trastuzumab deruxtecan therapy approved by CDSCO

    EXPRESSPHARMA

    AZ, Daiichi`s Enhertu tops SOC in early-stage breast cancer

    FIERCE PHARMA

    Enhertu + THP Boosts Complete Response in Breast Cancer Trial

    BUSINESSWIRE

    AstraZeneca`s enhertu improved pCR in early-stage breast cancer

    INDPHARMAPOST

    Enhertu Boosts Response in High-Risk HER2+ Breast Cancer

    BUSINESSWIRE

    Life Sciences Leaders Unify at Veeva Commercial Summit

    PR NEWSWIRE

    AZ`s $300M cell therapy manufacturing site opens in Maryland

    FIERCE PHARMA

    Pathos AI gets AZ funding as biotech plans to raise up to $400M

    ENDPTS

    AZ`s Breztri set up for label expansion with 2 asthma trial wins

    FIERCE PHARMA

    AstraZeneca`s `smoker`s lung` therapy meets main goals in trials

    REUTERS

    AstraZeneca unfolds 1st TV ad for breast cancer med Truqap

    FIERCE PHARMA

    AstraZeneca says potential US tariffs manageable

    REUTERS

    AstraZeneca`s Truqap falls short in another phase 3 trial

    FIERCE PHARMA

    AstraZeneca`s Q1 2025 Financial Results

    BUSINESSWIRE

    Onco-Innovations` Inka Health Sign New Work with AstraZeneca Canada

    ACCESSWIRE

    AstraZeneca says EU must invest to protect its `health sovereignty`

    REUTERS

    Tempus AI in line for $200M from AstraZeneca cancer model deal

    FIERCE BIOTECH

    AstraZeneca rejoins leading US drug lobby group after 2 year absence

    REUTERS

    AstraZeneca returns to industry association PhRMA

    FIERCE PHARMA

    Enhertu drives strong efficacy in first-line breast cancer

    BUSINESSWIRE

    AstraZeneca unit sued over alleged monopoly on drug Soliris

    REUTERS

    AstraZeneca Pharma India surrenders Olaparib marketing authorizat

    INDPHARMAPOST

    EU pharma firms demand to stay in EU amid expected US tariffs

    REUTERS

    AstraZeneca highlights infectious disease protection at ESCMID 2025

    INDPHARMAPOST

    Datroway® EU approval for metastatic HR+, HER2- breast cancer.

    BUSINESSWIRE

    Enhertu Approved in EU as First HER2 Therapy for HR+ Breast Cancer

    BUSINESSWIRE

    Inka Health Completes Analytics for AstraZeneca Canada

    ACCESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.